Your browser doesn't support javascript.
loading
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
Osawa, Mitsutaka; Uchida, Takuro; Imamura, Michio; Teraoka, Yuji; Fujino, Hatsue; Nakahara, Takashi; Ono, Atsushi; Murakami, Eisuke; Kawaoka, Tomokazu; Miki, Daiki; Tsuge, Masataka; Hiramatsu, Akira; Abe-Chayama, Hiromi; Hayes, C Nelson; Makokha, Grace Naswa; Aikata, Hiroshi; Ishida, Yuji; Tateno, Chise; Miyayama, Yohei; Hijikata, Makoto; Chayama, Kazuaki.
Afiliación
  • Osawa M; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Uchida T; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Imamura M; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Teraoka Y; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Fujino H; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Nakahara T; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Ono A; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Murakami E; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Kawaoka T; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Miki D; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Tsuge M; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Hiramatsu A; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Abe-Chayama H; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Hayes CN; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Makokha GN; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Aikata H; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Ishida Y; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Tateno C; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Miyayama Y; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, Japan.
  • Hijikata M; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
  • Chayama K; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
J Gen Virol ; 100(7): 1123-1131, 2019 07.
Article en En | MEDLINE | ID: mdl-31199224

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Pirrolidinas / Quinoxalinas / Sulfonamidas / Bencimidazoles / Hepatitis C / Hepacivirus / Farmacorresistencia Viral Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Gen Virol Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Pirrolidinas / Quinoxalinas / Sulfonamidas / Bencimidazoles / Hepatitis C / Hepacivirus / Farmacorresistencia Viral Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Gen Virol Año: 2019 Tipo del documento: Article País de afiliación: Japón